Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report

por van Ramshorst, Mette S, Kekana, Magdeline, Struthers, Helen E, McIntyre, James A, Peters, Remco PH
Publicado 2013

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and...

por van der Voort, Anna, Liefaard, Marte C., van Ramshorst, Mette S., van Werkhoven, Erik, Sanders, Joyce, Wesseling, Jelle, Scholten, Astrid, Vrancken Peeters, Marie Jeanne T.F.D., de Munck, Linda, Siesling, Sabine, Sonke, Gabe S.
Publicado 2022

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer

por Groen, Emma J., van der Noordaa, Marieke E. M., Schaapveld, Michael, Sonke, Gabe S., Mann, Ritse M., van Ramshorst, Mette S., Lips, Esther H., Vrancken Peeters, Marie-Jeanne T. F. D., van Duijnhoven, Frederieke H., Wesseling, Jelle
Publicado 2021

Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

por van Ramshorst, Mette S., Teixeira, Suzana C., Koolen, Bas B., Pengel, Kenneth E., Gilhuijs, Kenneth G., Wesseling, Jelle, Rodenhuis, Sjoerd, Valdés Olmos, Renato A., Rutgers, Emiel J., Vogel, Wouter V., Sonke, Gabe S., Vrancken Peeters, Marie-Jeanne T.
Publicado 2017